As expected, GIST-T1 cells showed apoptotic engagement when treated with imatinib and we detected an increase in cytochrome c release from inside the mitochondria and a curve shift upon BIM peptide exposure (increase in % priming) (Fig. 2a). This evidence concerns the gene CYCS and gastrointestinal stromal tumor.